Skip to main content

Table 1 Study timeline

From: Efficiency and effectiveness of the use of an acenocoumarol pharmacogenetic dosing algorithm versus usual care in patients with venous thromboembolic disease initiating oral anticoagulation: study protocol for a randomized controlled trial

Day

−3 or −2

0

3

7 (±1)

15 (±3)

30 (±5)

60 (±7)

90 (±7)

Recruitment

       

Informed consent

       

Selection criteria

       

Medical history

       

Physical examination

      

Blood samples for pharmacogenetics

       

Randomization

       

Acenocoumarol dosing (initiation/adjustment)a

 

INR determination

 

Evaluation of side effects

 

  1. aIn order to perform appropriate dose adjustments, additional visits can be scheduled as needed, at the discretion of the clinical researcher.